Chemoinformaics analysis of 4-Methylpentadecane
| Molecular Weight | 226.448 | nRot | 12 |
| Heavy Atom Molecular Weight | 192.176 | nRig | 0 |
| Exact Molecular Weight | 226.266 | nRing | 0 |
| Solubility: LogS | -7.057 | nHRing | 0 |
| Solubility: LogP | 8.1 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 49.391 |
| nHD | 0 | BPOL | 34.109 |
| QED | 0.34 |
| Synth | 2.249 |
| Natural Product Likeliness | 0.716 |
| NR-PPAR-gamma | 0.027 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.624 |
| MDCK | 0.00000851 |
| BBB | 0.194 |
| PPB | 0.984012 |
| VDSS | 3.514 |
| FU | 0.0187655 |
| CYP1A2-inh | 0.446 |
| CYP1A2-sub | 0.198 |
| CYP2c19-inh | 0.409 |
| CYP2c19-sub | 0.196 |
| CYP2c9-inh | 0.177 |
| CYP2c9-sub | 0.935 |
| CYP2d6-inh | 0.241 |
| CYP2d6-sub | 0.056 |
| CYP3a4-inh | 0.205 |
| CYP3a4-sub | 0.063 |
| CL | 5.154 |
| T12 | 0.065 |
| hERG | 0.16 |
| Ames | 0.006 |
| ROA | 0.026 |
| SkinSen | 0.947 |
| Carcinogencity | 0.035 |
| EI | 0.945 |
| Respiratory | 0.419 |
| NR-Aromatase | 0.015 |
| Antiviral | Yes |
| Prediction | 0.68913 |